Baby Santhosh M, May Walter J, Getsy Paulina M, Coffee Gregory A, Nakashe Tej, Bates James N, Levine Alan, Lewis Stephen J
Department of Drug Discovery, Galleon Pharmaceuticals, Inc., Horsham, PA, United States.
Pediatric Respiratory Medicine, University of Virginia School of Medicine, Charlottesville, VA, United States.
Front Pharmacol. 2024 Apr 18;15:1381073. doi: 10.3389/fphar.2024.1381073. eCollection 2024.
Fentanyl elicits profound disturbances in ventilatory control processes in humans and experimental animals. The traditional viewpoint with respect to fentanyl-induced respiratory depression is that once the effects on the frequency of breathing (Freq), tidal volume (TV), and minute ventilation (MV = Freq × TV) are resolved, then depression of breathing is no longer a concern. The results of the present study challenge this concept with findings, as they reveal that while the apparent inhibitory effects of fentanyl (75 μg/kg, IV) on Freq, TV, and MV in adult male rats were fully resolved within 15 min, many other fentanyl-induced responses were in full effect, including opposing effects on respiratory timing parameters. For example, although the effects on Freq were resolved at 15 min, inspiratory duration (Ti) and end inspiratory pause (EIP) were elevated, whereas expiratory duration (Te) and end expiratory pause (EEP) were diminished. Since the effects of fentanyl on TV had subsided fully at 15 min, it would be expected that the administration of an opioid receptor (OR) antagonist would have minimal effects if the effects of fentanyl on this and other parameters had resolved. We now report that the intravenous injection of a 1.0 mg/kg dose of the peripherally restricted OR antagonist, methyl-naloxone (naloxone methiodide, NLXmi), did not elicit arousal but elicited some relatively minor changes in Freq, TV, MV, Te, and EEP but pronounced changes in Ti and EIP. In contrast, the injection of a 2.5 mg/kg dose of NLXmi elicited pronounced arousal and dramatic changes in many variables, including Freq, TV, and MV, which were not associated with increases in non-apneic breathing events such as apneas. The two compelling conclusions from this study are as follows: 1) the blockade of central ORs produced by the 2.5 mg/kg dose of NLXmi elicits pronounced increases in Freq, TV, and MV in rats in which the effects of fentanyl had apparently resolved, and 2) it is apparent that fentanyl had induced the activation of two systems with counter-balancing effects on Freq and TV: one being an opioid receptor inhibitory system and the other being a non-OR excitatory system.
芬太尼会在人类和实验动物的通气控制过程中引发严重紊乱。关于芬太尼所致呼吸抑制的传统观点是,一旦对呼吸频率(Freq)、潮气量(TV)和分钟通气量(MV = Freq×TV)的影响得到解决,那么呼吸抑制就不再是问题。本研究结果对这一概念提出了挑战,因为研究结果显示,虽然芬太尼(75μg/kg,静脉注射)对成年雄性大鼠的Freq、TV和MV的明显抑制作用在15分钟内完全消除,但许多其他由芬太尼引起的反应仍在充分发挥作用,包括对呼吸时间参数的相反作用。例如,虽然对Freq的影响在15分钟时已消除,但吸气持续时间(Ti)和吸气末暂停(EIP)增加,而呼气持续时间(Te)和呼气末暂停(EEP)减少。由于芬太尼对TV的影响在15分钟时已完全消退,如果芬太尼对该参数及其他参数的影响已得到解决,那么预计给予阿片受体(OR)拮抗剂的作用将微乎其微。我们现在报告,静脉注射1.0mg/kg剂量的外周限制型OR拮抗剂甲基纳洛酮(纳洛酮甲碘化物,NLXmi)并未引起觉醒,但在Freq、TV、MV、Te和EEP方面引起了一些相对较小的变化,而在Ti和EIP方面引起了明显变化。相比之下,注射2.5mg/kg剂量的NLXmi引起了明显的觉醒,并在许多变量中引起了显著变化,包括Freq、TV和MV,这些变化与呼吸暂停等非呼吸暂停性呼吸事件的增加无关。本研究得出的两个令人信服的结论如下:1)2.5mg/kg剂量的NLXmi对中枢OR的阻断在芬太尼作用明显消退的大鼠中引起了Freq、TV和MV的显著增加;2)显然,芬太尼诱导了两个对Freq和TV具有平衡作用的系统的激活:一个是阿片受体抑制系统,另一个是非OR兴奋系统。